Results 191 to 200 of about 35,846 (211)

State of the science on prevention and screening to reduce melanoma incidence and mortality: The time is now

Ca-A Cancer Journal for Clinicians, 2016
Susan M Swetter
exaly  

[DPP-4 inhibitor (incretin enhancer)].

Nihon rinsho. Japanese journal of clinical medicine, 2012
Jun-Ichiro, Miyagawa, Mitsuyoshi, Namba
openaire   +1 more source

Cancer screening in the United States, 2016: A review of current American Cancer Society guidelines and current issues in cancer screening

Ca-A Cancer Journal for Clinicians, 2016
Robert A Smith, Stacey A Fedewa, Joannie Lortet-Tieulent   +2 more
exaly  

Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer‐related cognitive impairment in adults

Ca-A Cancer Journal for Clinicians, 2015
Jeffrey S Wefel, Shelli R Kesler
exaly  

Cancer screening, prevention, and treatment in people with mental illness

Ca-A Cancer Journal for Clinicians, 2016
Ana Stefancic, Amy T Cunningham, Richard C Wender   +2 more
exaly  

Trough DPP-4 Inhibition Differs between the Approved DPP-4 Inhibitors

MD Conference Express, 2013
openaire   +1 more source

Cancer screening in the United States, 2014: A review of current American Cancer Society guidelines and current issues in cancer screening

Ca-A Cancer Journal for Clinicians, 2014
Robert A Smith
exaly  

DPP-4 Inhibitor-associated Bullous Pemphigoid

Nishi Nihon Hifuka, 2016
openaire   +1 more source

Breast cancer statistics, 2015: Convergence of incidence rates between black and white women

Ca-A Cancer Journal for Clinicians, 2016
Carol E Desantis, Ann Goding Sauer Msph, Robert A Smith   +2 more
exaly  

Cancer screening in the United States, 2015: A review of current American Cancer Society guidelines and current issues in cancer screening

Ca-A Cancer Journal for Clinicians, 2015
Robert A Smith
exaly